Clinical trial
A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
NCT02850718 is registered in ClinicalTrials.gov with iX Biopharma Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
- Lead sponsor
- iX Biopharma Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- May 31, 2016
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.